Others
Description
Min. Order:1 Gram
Payment Type:T/T,L/C,Western Union
Transportation:Ocean,Land,Air,Fedex
Productivity:100G
Packaging:1g/bag
Delivery Time:7 Days
Product Description
Dalbavancin is a novel second-generation lipoglycopeptide antibiotic. It belongs to the same class as vancomycin, the most widely used and one of the few treatments available to patients infected with methicillin-resistant Staphylococcus aureus (MRSA). Dalbavancin is a semisynthetic lipoglycopeptide that was designed to improve upon the natural glycopeptides currently available, vancomycin and teicoplanin. It possesses in vitro activity against a variety of Gram-positive pathogens including MRSA and methicillin-resistant Staphylococcus epidermidis (MRSE). Dalbavancin was approved in May 2014 for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) caused by certain susceptible bacteria such as Staphylococcus aureus including methicillin-susceptible and methicillin-resistant strains of Streptococcus pyogenes, in intravenous dosage form.
http://www.crenelab.com/custom-synthesis/22463588.html
http://www.crenelab.com/custom-synthesis/
Read More
Taizhou Crene Biotechnology Co., Ltd.
API Inhibitors , pharmaceutical
Address: Economic Developed Zone , Taizhou, Zhejiang, China,
Taizhou, Zhejiang
China, 318000
Tel: 86-576-88205808
Fax: 86-576-88229589
